Clinical Trials Browser

Phase 2 × IFL protocol × Tumor-Agnostic × Clear all

NCT03806309 2025-07-25

TEDOPAM

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT01543412 2012-03-05

SLAP

Phase 2 Completed

Neoplasm Metastasis